In any event, good luck to you. From what I've seen from the inside, newer tech stacks can deal some serious disruption in a very short time frame.
I totally get how it is a compelling story for investors, but I have serious doubts about adoption and use.
It was my experience that data and sound record keeping was a secondary to approvals. Many times paperwork was "corrected" and patients were excluded because of serious adverse events. Unless your model is to help identify exclusionary criteria retroactively?
This is happening across all enterprise verticals, and this is why there is such an opportunity for enterprise startups. As Warren Hogarth says in the original article "There’s about a trillion dollars of enterprise software", much of which will "transition to [specialized] enterprise software... and create multi-billion dollar companies".
How did you guys come up with this idea?
Are you guys working on that, or is it just 'assumed' that your stack and cloud capability is compliant?
We're tackling eTMF plus other R&D from a content perspective through SaaS. See you're integrating with Medidata as well.
Greetings from Pleasanton ;)